HopeStage
Back to all studies
CompletedNCT04689282

Nasal bioactive factors for children’s speech difficulties

About this titleRead the official source — NCT04689282
Interventional studyAges 3–18RussiaADHD
The study in practice

Understand this study

Who was this study for?

Listed age limits: 3 years to 18 years.

Listed locations
NovosibirskSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 1, 2020
Recruitment status
Completed
Enrollment listed in the registry
14
Sponsor
Russian Academy of Medical Sciences
Sponsor type
Unknown or unclear
Study type
Biological
Intervention type
Biological
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Russia
Age range
From 3 Years to 18 Years
Official registry ID
NCT04689282
Official title
Show the full official title

Safety/Efficacy of Intranasally-Administered Bioactive Factors Produced by M2 Type Macrophages in Children With Developmental Speech Disorders

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Novosibirsk, Russia · Russia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Russian Academy of Medical Sciences.

Who was this study for?

Listed age limits: 3 years to 18 years.

Want to explore more studies?

Explore studies